Fungal peritonitis in children on peritoneal dialysis at a tertiary care Centre

BMC Nephrology

Table 1 Patients primary diagnosis and microbiological characteristics of each FP episode (n = 11)

Primary Diagnosis	Time between PD insertion and first FP (Months)	Previous Peritonitis	Anti-fungal Prop.	G Tube	Culture and Sensitivity	Duration of Therapy (Weeks)	Antimicrobial Treatment	Route of Antibiotic Administration	Outcome of Peritonitis	Antibiotic Use 1 Month Prior to FP Episode
SDK	1	Yes	Yes	No	Candida albicans	3	Caspofungin	IV	CRS-HD	Yes
CNS	28	Yes	No	No	Rhodotorula	2	Amphotericin B	IV	CRS-HD	No
CNS	37	Yes	No	No	Candida parapsilosis	2	Fluconazole	IV/IP	CRS-HD-D	No
INS	20	Yes	No	Yes	Aspergillus flavus	3	Voriconazole	PO	CRS-HD^a	No
PKD	36	Yes	Yes	No	Candida famata	3	Amphotericin B	IV	CRS-HD^a	Yes
HPK	20	No	No	No	Candida lusitaniae	3	Caspofungin	IV	CRS-HD	No
INS	2	Yes	Yes	Yes	Candida albicans	2	Fluconazole	IV	CRS-HD	Yes
CNS	14	No	No	No	Candida dubliniensis	2	Fluconazole	IV	CRS-HD	No
CNS^b	12	No	No	No	Candida parapsilosis	2	Fluconazole	IV/IP	CRS-HD^a	No
CNS^b	16	Yes	No	No	Candida tropicalis	3	Fluconazole	IV/IP	CRS-HD	No
PKD	21	Yes	Yes	No	Candida famata	4	Caspofungin	IV	CRS-HD	Yes

^a Temporary haemodialysis
^b same patient had 2 FP episodes
FP fungal peritonitis, G tube gastrostomy tube, ep episode, SDK single dysplastic kidney, CNS congenital nephrotic syndrome, INS infantile nephrotic syndrome, HPK hypoplastic kidney, PKD polycystic kidney disease, prop. prophylaxis, CRS-HD catheter removed and patient shifted to haemodialysis, D death, IV intravenous, IP intraperitoneal, PO oral

ISSN: 1471-2369